Share tips 2026: this week’s top stock picks

Jump to category:

Three stocks to buy
One stock to sell
...and the rest

If you’ve been keeping a close eye on share tips 2026, then don’t miss this weekly round-up of the top stocks to consider for your portfolio.

The MoneyWeek share tips 2026 guide pulls together some of the best stocks from top share tipsters around.

Article continues below

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Investors will undoubtedly want to refresh their finances this year – we look at dividend heroes, what's happening with gold prices and the best way to invest. If you're new to investing, here's how to start.

Three stocks to buy

1. ITV (LSE: ITV)
Investors' Chronicle
ITV is shifting towards digital advertising and content production as television advertising declines. The broadcaster's annual pre-tax profit dropped over 33% in 2025 owing to a strong previous year that included profit from selling its stake in streaming-service BritBox. The media and entertainment unit reported lower revenue. If ITV sells this unit to Sky for £1.6 billion, it would bolster its growth prospects, allowing it to focus on its successful studio arm behind hit shows like Love Island. The stock looks “cheap”. 84p

2. Freeport-McMorRan (NYSE: FSX)
Barron’s
Shares in America's largest copper miner, Freeport-McMoRan, dropped 10% after markets were rocked by the Iran war and rising oil prices. This dip provides a “compelling buying opportunity”, with analysts forecasting a big rise in copper prices thanks to growing demand for copper used for data centres, AI and the energy transition. Volatility from geopolitical turmoil is a risk, but the miner has a “healthy” balance sheet and its shares are cheap compared with rivals. $59

3. Hunting (LSE: HTG)
Investor's Chronicle
Hunting, which makes parts for the oil and gas services sector, reported a 7% rise in adjusted profits to $135 million for 2025, thanks to cost cuts. The firm plans a $40 million buyback. It forecasts cash profits of $145 million to $155 million this year, despite a potential fall in orders amid the Gulf conflict. Hunting says it has “minimal exposure” to the Middle East thanks to a focus on offshore and subsea markets. Its outlook and valuation “keep us positive”. 496p

One stock to sell

1. Reach (LSE: RCH)
Investors’ Chronicle
Reach, publisher of the Daily Mirror and Daily Express, reported a £223 million non-cash impairment charge for 2025 owing to unexpectedly low digital revenues, which dropped 0.9% on reduced referral traffic from Google. This led to a £160 million operating loss, down from a £74 million profit in 2024. Adjusted operating profits rose slightly amid “aggressive” job cuts, but circulation volumes fell 19% and print revenue declined 4.6%. The media group is rolling out digital subscriptions but remains cautious. While the dividend was maintained, net debt grew and the outlook is “grim”. Reach is “cheap” for a “good reason”. 62p

Two stocks to consider

1. Cadre Holdings (NYSE: CDRE)
Barron's
Cadre Holdings supplies riot equipment, communications systems and other products to law enforcement and US agencies. The stock has doubled in the past three years, benefiting from more police funding and a push into the nuclear industry. The US company is profitable and generates strong cash flow. It expects net sales to rise about 10% this year to $627 million. Cadre's revenue relies heavily on government budgets and faces risks from political uncertainty, but its future looks promising. Buy ($32).

2. Elementis (LSE: ELM)
Investors' Chronicle
Speciality-chemicals company Elementis is to become even more specialised as it restructures to refocus on coatings and personal care. The firm has sold its pharmaceutical contract-manufacturing arm for €34 million and its talc business for $121 million; it bought personal-care products firm Alchemy Ingredients for $22 million. CEO Luc van Ravenstein said “niche, high-value products” were key to achieving its medium-term target of a 30% return on capital employed (ROCE). Elementis's strategy looks “logical”. Investors “should back a share price that has recovered from last year's lows”. Buy (152p).

This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.